Cargando…
Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress...
Autores principales: | Tavakoli, Mahin, Shokohi, Tahereh, Lass Flörl, Cornelia, Hedayati, Mohammad Taghi, Hoenigl, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Medical Mycology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226042/ https://www.ncbi.nlm.nih.gov/pubmed/34195465 http://dx.doi.org/10.18502/cmm.6.4.5442 |
Ejemplares similares
-
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020) -
The first rare and fatal case of invasive aspergillosis of spinal cord due to Aspergillus nidulans in an Iranian child with chronic granulomatosis disease: review of literature
por: Tavakoli, Mahin, et al.
Publicado: (2020) -
Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011) -
Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro
por: Maurer, Elisabeth, et al.
Publicado: (2019) -
1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)